Resilience plans to lay off 120 workers at its Research Triangle Park facility in Durham, North Carolina ... adding around 440 new jobs at a former AstraZeneca plant in West Chester, Ohio.

A pair of Japanese firms are investing in a huge housing development in Durham. STORY HIGHLIGHTS Crescent ... More international investment is coming to the Triangle as part of a Charlotte ...

The Tax Cuts and Jobs Act of 2017 reconfigured the tax code. Did it also enable a pharmaceutical giant to invest in Wake ...

A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to address concerns over its business in China than on its earnings report alone.

LONDON, Jan 31 (Reuters) - AstraZeneca (AZN.L), opens new tab on ... Anglo-Swedish drugmaker's $2 billion spending proposal on research and development and manufacturing plants in the United ...

Some of the biggest companies in Research Triangle Park will play a key role in deciding its future development path.

AstraZeneca has abandoned a £450m investment in a major UK vaccine plant just days after Rachel Reeves vowed to “kick-start economic growth”. The drugmaker, which is Britain’s most valuable ...

In substance and timing, AstraZeneca's decision to cancel a planned expansion of its flu vaccine facility at Speke is a blow to the government's recent zeal for growth. Instead of injecting £450m ...

Research Triangle Park now has door-to-door mail delivery service from the U.S. Postal Service for the first time in the park ...

AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government. The investment, announced last year in the Tories' spring budget ...

An AstraZeneca and Daiichi Sankyo drug designed to replace chemotherapy was cleared by US regulators for broader use in late-stage breast cancer patients. The Food and Drug Administration ...

Confirming the reversal on Friday, a spokesperson for AstraZeneca said: "Following discussions with the current Government, we are no longer pursuing our planned investment in Speke. "Several factors ...